Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea

European Journal of Pharmacology

Volumn 304, Issue 1-3, 1996, Pages 123-128

  Gater, Paul R ^a   Wasserman, Martin A ^a,b   Renzetti, Louis M ^a  

^a HOFFMANN LA ROCHE INC   (United States)

^b Merrell Dow Research Institute   (United States)

Author keywords

BQ123; bronchus, human; endothelin receptor antagonist; endothelin receptor subtype; endothelin 1; Ro 47 0203; sarafotoxin S6c; trachea, guinea pig

Indexed keywords

ACETYLCHOLINE; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; INDOMETACIN; RECEPTOR SUBTYPE; SARAFOTOXIN S6C;

ADULT; ANIMAL TISSUE; ARTICLE; BRONCHUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DONOR; DRUG ANTAGONISM; FEMALE; GUINEA PIG; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; SPECIES DIFFERENCE; TRACHEA;

EID: 0030598620     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00125-2     Document Type: Article

References (23)

1. Arai, H., S, Hori, I. Aramori, H. Ohkubo and S. Nakanishi, 1990, Cloning and expression of a cDNA encoding an endothelin receptor, Nature 348, 730.
2. Arunlakshana, O. and H.O. Schild, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. Chemother. 14, 48-58.
3. B receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065, Br. J. Pharmacol. 111, 1009.
4. Bax, W.A. and P.R. Saxena, 1994, The current endothelin receptor classification: time for reconsideration?, Trends Pharmacol. Sci. 15, 379.
5. Clozel, M., V. Breu, G.A. Gray, B. Kalina, B.-M. Loffler, K. Burri, J.-M. Cassal, G. Hirth, M. Muller, W. Neidhart and H. Ramuz, 1994, Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist, J. Pharmacol. Exp. Ther. 270, 228.
6. Druml, W., H. Steltzer, W. Waldhäusl, K. Lenz, A. Hammerle, H. Vierhapper, S. Gasic and O.F. Wagner, 1993, Endothelin-1 in adult respiratory distress syndrome, Am. Rev. Respir. Dis. 148, 1169.
7. Gater, P.R., M.A. Wasserman and L.M. Renzetti, 1994, Contraction of human bronchus to endothelin is mediated by an atypical receptor, Can. J. Physiol. Pharmacol. 72, (Suppl. 1), 495.
8. Goldie, R.G., P.J. Henry, P.G. Knott, G.J. Self, M.A. Luttmann and D.W.P. Hay, 1995. Endothelin-1 receptor density, distribution and function in human isolated asthmatic airways, Am. J. Respir. Crit. Care Med. 152, 1653.
9. Hay, D.W.P., P.J. Henry and R.G. Goldie, 1993a, Endothelin and the respiratory system. Trends Pharmacol. Sci. 14, 29.
10. Hay, D.W.P., M.A. Luttmann, W.C. Hubbard and B.J. Undem, 1993b, Endothelin receptor subtypes in human and guinea-pig pulmonary tissues, Br. J. Pharmacol. 110, 1175.
11. Huggins, J.P., J.T. Pelton and R.C. Miller, 1993, The structure and specificity of endothelin receptors: their importance in physiology and medicine, Pharmacol. Ther. 59, 55.
12. A receptor, Life Sci. 50, 247.
13. Ishikawa, K., M. Ihara, K. Noguchi, T. Mase, N. Mino, T. Saeki, T. Fukuroda, T. Fukami, S. Ozakari, T. Nagase, M. Nishikibe and M. Yano, 1994, Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788, Proc. Natl. Acad. Sci. USA 91, 4892.
14. Knott, P.G., A.C. D'Aprile, P.J. Henry, D.W.P. Hay and R.G. Goldie, 1995, Receptors for endothelin-1 in asthmatic human peripheral lung, Br. J. Pharmacol. 114, 1.
15. Mullol, J., B.A. Chowdhury and M.V. White, 1993, Endothelin in human nasal mucosa, Am. J. Respir. Cell Mol. Biol. 8, 393.
16. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyasaki, S. Kimura, K. Goto and T. Masaki, 1990, Cloning of a cDNA encoding a non-iso-peptide-selective subtype of the endothelin receptor, Nature 348, 732.
17. Sofia, M., M. Mormile, S. Faraone, S. Zofra, L. Romano and L. Carratù, 1993, Increased endothelin-like immunoreactive material in broncho-alveolar lavage fluid from patients with bronchial asthma and patients with interstitial lung disease. Respiration 60, 89.
18. Springall, D.R., P.M. Howarth, H. Counihan, R. Djukanovic, S.T. Holgate and J.M. Polak, 1991, Endothelin immunoreactivity of airway epithelium in asthmatic patients, Lancet 337, 697.
19. Tanaka, T., E. Tsukuda, M. Nozawa, H. Nonaka, T. Ohno, H. Kase, K. Yamada and Y. Matsuda, 1994, RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin, Mol. Pharmacol. 45, 724.
20. 125I]endothelin-1 binding data, Life Sci. 51, 1869.
21. Williams, D.L. Jr., K.L. Jones, D.J. Pettibone, E.V. Lis and B.V. Clineschmidt, 1991, Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes, Biochem. Biophys. Res. Commun. 162, 371.
22. Wu-Wong, J.R., W.J. Chiou, S.R. Magnuson and T.J. Opgenorth, 1994, Endothelin receptor agonists and antagonists exhibit different dissociation characteristics, Biochim. Biophys. Acta 1224, 288.
23. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto and T. Masaki, 1988, A novel vasoconstrictor peptide produced by vascular endothelial cells, Nature 332, 411.